Botswana AMR Implementation Guide
0.1.0 - 0.1.0

Botswana AMR Implementation Guide - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

: Botswana AMR Interpretation - TTL Representation

Draft as of 2026-03-13

Raw ttl | Download


@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

# - resource -------------------------------------------------------------------

 a fhir:ValueSet ;
  fhir:nodeRole fhir:treeRoot ;
  fhir:id [ fhir:v "botswana-amr-interpretation"] ; # 
  fhir:text [
fhir:status [ fhir:v "extensions" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet botswana-amr-interpretation</b></p><a name=\"botswana-amr-interpretation\"> </a><a name=\"hcbotswana-amr-interpretation\"> </a><ul><li>Include these codes as defined in <a href=\"http://terminology.hl7.org/6.0.2/CodeSystem-v3-ObservationInterpretation.html\"><code>http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation</code></a><span title=\"Version is not explicitly stated, which means it is fixed to 3.0.0, the version found through the package references\"> version ?3.0.0</span><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td><a href=\"http://terminology.hl7.org/6.0.2/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-S\">S</a></td><td>Susceptible</td><td>Bacterial strain inhibited by in vitro concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic success. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\\_Terminolo.htm) Synonym (earlier term): Sensitive Projects: ISO 20776-1, ISO 20776-2<br/><br/>\\[Note 1: Bacterial strains are categorized as susceptible by applying the appropriate breakpoints in a defined phenotypic system.\\]<br/><br/>\\[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\\]</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.0.2/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-I\">I</a></td><td>Intermediate</td><td>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with uncertain therapeutic effect. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2<br/><br/>\\[Note 1: Bacterial strains are categorized as intermediate by applying the appropriate breakpoints in a defined phenotypic test system.\\]<br/><br/>\\[Note 2: This class of susceptibility implies that an infection due to the isolate can be appropriately treated in body sites where the drugs are physiologically concentrated or when a high dosage of drug can be used.\\]<br/><br/>\\[Note 3: This class also indicates a \"buffer zone,\" to prevent small, uncontrolled, technical factors from causing major discrepancies in interpretations.\\]<br/><br/>\\[Note 4: These breakpoints can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\\]</td></tr><tr><td><a href=\"http://terminology.hl7.org/6.0.2/CodeSystem-v3-ObservationInterpretation.html#v3-ObservationInterpretation-R\">R</a></td><td>Resistant</td><td>Bacterial strain inhibited in vitro by a concentration of an antimicrobial agent that is associated with a high likelihood of therapeutic failure. Reference: CLSI (http://www.clsi.org/Content/NavigationMenu/Resources/HarmonizedTerminologyDatabase/Harmonized\\_Terminolo.htm) Projects: ISO 20776-1, ISO 20776-2<br/><br/>\\[Note 1: Bacterial strains are categorized as resistant by applying the appropriate breakpoints in a defined phenotypic test system.\\]<br/><br/>\\[Note 2: This breakpoint can be altered due to changes in circumstances (e.g., changes in commonly used drug dosages, emergence of new resistance mechanisms).\\]</td></tr></table></li></ul></div>"^^rdf:XMLLiteral ]
  ] ; # 
  fhir:url [
fhir:v "http://bw.health.gov/fhir/amr/ValueSet/botswana-amr-interpretation"^^xsd:anyURI ;
fhir:l <http://bw.health.gov/fhir/amr/ValueSet/botswana-amr-interpretation>
  ] ; # 
  fhir:version [ fhir:v "0.1.0"] ; # 
  fhir:name [ fhir:v "BotswanaAMRInterpretation"] ; # 
  fhir:title [ fhir:v "Botswana AMR Interpretation"] ; # 
  fhir:status [ fhir:v "draft"] ; # 
  fhir:date [ fhir:v "2026-03-13T21:27:21-04:00"^^xsd:dateTime] ; # 
  fhir:publisher [ fhir:v "University of Botswana Partnership"] ; # 
  fhir:contact ( [
fhir:name [ fhir:v "University of Botswana Partnership" ] ;
    ( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://github.com/Dokotela/bw-amr-ig" ]     ] )
  ] ) ; # 
  fhir:description [ fhir:v "Only Susceptible, Intermediate, or Resistant"] ; # 
  fhir:compose [
    ( fhir:include [
fhir:system [
fhir:v "http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation"^^xsd:anyURI ;
fhir:l <http://terminology.hl7.org/CodeSystem/v3-ObservationInterpretation>       ] ;
      ( fhir:concept [
fhir:code [ fhir:v "S" ] ;
fhir:display [ fhir:v "Susceptible" ]       ] [
fhir:code [ fhir:v "I" ] ;
fhir:display [ fhir:v "Intermediate" ]       ] [
fhir:code [ fhir:v "R" ] ;
fhir:display [ fhir:v "Resistant" ]       ] )     ] )
  ] . #